CW April 2003Issue Number 4 April 2003 ISSN 10593802 Comparable Therapies in Metastatic Colorectal CancerComparable efficacy with oxaliplatin and irinotecan, the major new players in metastatic colorectal cancer, suggest that their differing toxicity profiles may be the basis for treatment choices.
Go to Previous Page Go to Next Page Source & Additional Reading L. Saltz, National Comprehensive Cancer Network Annual Meeting presentation, ?Update: Colorectal Cancer Guidelines.?. Purchase Downloadable Full-text PDF of Article: $10.00 Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details. Download Complete Issue CW April 2003Purchase Downloadable Full-text PDF of Complete Issue: $20.00 |
|
Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us
Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA |
Re-initialize IP-based Login |